Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 43 min ago
Peer-reviewedCC BY 4.0Nutrients

Gut Microbiome in Sporadic Cerebral Small Vessel Disease: MRI-Defined Phenotypes, Mechanistic Evidence, and Nutritional Implications for Brain Aging

7 affiliations
  1. 1Department of Neurology and Stroke, Saint John’s Central Hospital of North Buda, 1125 Budapest, Hungary
  2. 2Health Sciences Division, Doctoral College, Semmelweis University, 1085 Budapest, Hungary
  3. 3MiND Brain-Gut Center, 1125 Budapest, Hungary
  4. 4Department of Pulmonology, Semmelweis University, 1083 Budapest, Hungary
  5. 5Institute of Preventive Medicine and Public Health, Faculty of Medicine, Semmelweis University, 1089 Budapest, Hungary
  6. 6Fodor Center for Prevention and Healthy Aging, Semmelweis University, 1085 Budapest, Hungary
  7. 7Faculty of International Business Economics, Budapest University of Economics and Business, 1054 Budapest, Hungary

Abstract

Background/Objectives: Cerebral small vessel disease (CSVD) is a major vascular component of brain aging, yet potentially modifiable systemic contributors remain incompletely understood. Growing evidence links the gut microbiome to magnetic resonance imaging (MRI)-defined CSVD, but interpretation is complicated by heterogeneity in microbiome profiling, clinical populations, analytical methods, and neuroimaging phenotypes. This review critically integrates the available human evidence with complementary multi-omics, ex vivo, and experimental findings. Methods: PubMed, Embase, Scopus, and Web of Science were searched through 4 August 2026; 12 eligible reports representing eight cohort families were included and evaluated using a structured study-level methodological appraisal. Results: Across the available literature, ecological and host-related biological processes show greater qualitative convergence than individual taxa, although this pattern has not been formally quantified across independent cohorts. Among reported alpha diversity measures, Chao/Chao1 showed the same numerical disease-versus-control direction across four cohort families, with statistical significance in two, suggesting a recurrent but still preliminary richness-related signal; Shannon and Simpson indices were less consistent. No single genus or species has been consistently replicated across the available, largely cross-sectional cohorts. Complementary studies implicate intestinal barrier, immune–metabolic, neurovascular, and perivascular clearance pathways but do not establish a unified causal pathway in human sporadic CSVD. Conclusions: These observations support a hypothesis-generating ecosystem-level framework. Because diet is an important modifiable determinant of the gut microbial ecosystem, these findings may have relevance for nutrition-based strategies targeting vascular brain aging. However, no CSVD-specific dietary or microbiome-directed intervention has yet been shown to modify disease progression or related MRI outcomes.

Related

  1. Nutritional modulation of microbiome proteomics in insulin resistance
    Beraat Dener, Sueda İzem Gülal, Miraç Bulut +3
    Frontiers in NutritionPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationPMC
  2. Microbiome-targeted strategies for Alzheimer’s disease: multi-omics signatures, mechanistic links, and intervention evidence
    Xuyang Huang, Xinyue Zhang, Qi Zhu
    Frontiers in MicrobiologyPeer-reviewedCC BY 4.0Molecular biology & gene regulationCrossref
  3. Exercise and immune system as modulators of intestinal microbiome: implications for the gut-muscle axis hypothesis
    Andrea Ticinesi, Fulvio Lauretani, Claudio Tana +3
    PubMedPeer-reviewedLicence not stated146 citedMolecular biology & gene regulationOpenAlex
  4. HMGB1 in Amyloid-Beta Pathology: Mechanistic Insights and Therapeutic Implications for Alzheimer’s Disease
    Song-I Seol, Ji-Eun Kim, Dashdulam Davaanyam +5
    International journal of molecular sciencesPeer-reviewedCC BYFull textGeneral biochemistryEurope PMC
  5. Exercise Training, Lipoprotein Subfractions, and Molecular Lipidomics: Mechanistic Insights into Atherogenic Risk Phenotypes—A Structured Narrative Review
    Cemre Can Akkaya, Zahra Eslamı, Abdorreza Eghbal Moghanlou +4
    MetabolitesPeer-reviewedCC BY 4.0Proteomics & metabolomicsCrossref
BibTeX
@article{jarecsny2026microbiome,
  title = {{Gut Microbiome in Sporadic Cerebral Small Vessel Disease: MRI-Defined Phenotypes, Mechanistic Evidence, and Nutritional Implications for Brain Aging}},
  author = {Tamas Jarecsny and Ferenc Fazekas and Nadim Al-Muhanna and Richard Schwab and Viktoria Hadnagy and Sara Laki and Janos Tamas Varga and Andrea Lehoczki and Virag Zabo and Diana Gorog and Monika Fekete},
  journal = {Nutrients},
  year = {2026},
  month = oct,
  doi = {10.3390/nu18203421},
  url = {https://www.mdpi.com/2072-6643/18/20/3421},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Gut Microbiome in Sporadic Cerebral Small Vessel Disease: MRI-Defined Phenotypes, Mechanistic Evidence, and Nutritional Implications for Brain Aging
AU  - Tamas Jarecsny
AU  - Ferenc Fazekas
AU  - Nadim Al-Muhanna
AU  - Richard Schwab
AU  - Viktoria Hadnagy
AU  - Sara Laki
AU  - Janos Tamas Varga
AU  - Andrea Lehoczki
AU  - Virag Zabo
AU  - Diana Gorog
AU  - Monika Fekete
PY  - 2026
DA  - 2026/10/01
JO  - Nutrients
DO  - 10.3390/nu18203421
UR  - https://www.mdpi.com/2072-6643/18/20/3421
AB  - Background/Objectives: Cerebral small vessel disease (CSVD) is a major vascular component of brain aging, yet potentially modifiable systemic contributors remain incompletely understood. Growing evidence links the gut microbiome to magnetic resonance imaging (MRI)-defined CSVD, but interpretation is complicated by heterogeneity in microbiome profiling, clinical populations, analytical methods, and neuroimaging phenotypes. This review critically integrates the available human evidence with complementary multi-omics, ex vivo, and experimental findings. Methods: PubMed, Embase, Scopus, and Web of Science were searched through 4 August 2026; 12 eligible reports representing eight cohort families were included and evaluated using a structured study-level methodological appraisal. Results: Across the available literature, ecological and host-related biological processes show greater qualitative convergence than individual taxa, although this pattern has not been formally quantified across independent cohorts. Among reported alpha diversity measures, Chao/Chao1 showed the same numerical disease-versus-control direction across four cohort families, with statistical significance in two, suggesting a recurrent but still preliminary richness-related signal; Shannon and Simpson indices were less consistent. No single genus or species has been consistently replicated across the available, largely cross-sectional cohorts. Complementary studies implicate intestinal barrier, immune–metabolic, neurovascular, and perivascular clearance pathways but do not establish a unified causal pathway in human sporadic CSVD. Conclusions: These observations support a hypothesis-generating ecosystem-level framework. Because diet is an important modifiable determinant of the gut microbial ecosystem, these findings may have relevance for nutrition-based strategies targeting vascular brain aging. However, no CSVD-specific dietary or microbiome-directed intervention has yet been shown to modify disease progression or related MRI outcomes.
SN  - 2072-6643
ER  -